Patent · US Active

Pyrrolo[1,2-b]pyridazine derivatives

US11053250B2 · kind B2 · utility

0Cited by
1References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2019
Grant dateJul 6, 2021
Priority date—
Expiry dateAug 9, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.